Atlas Trials

Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer

Clinical trial NCT03198923 · UNKNOWN

Trial details

NCT number
NCT03198923
Sponsor
Wenxiang Wang
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2017-09-13
Primary completion
2018-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.